As HMA has grown, we have added significant breadth and depth to our Medicare team to better offer our clients comprehensive expertise on Medicare, Medicare Advantage, Dual-Eligibles, payment systems, pricing, and more. When looking for a partner to help navigate the complexities and changes of Medicare, our clients know that by engaging HMA experts they are engaging former CMS officials, former plan executives, payment system and coding experts, policy analysts, and many others. We draw on the resources of experts from our HMA companies to provide comprehensive and end-to-end solutions, including Wakely Consulting Group and Cirdan Health Systems and Consulting for actuarial services, and Leavitt Partners for political and policy engagement. Together we bring considerable expertise in all things Medicare and can leverage our more than 700 consulting colleagues across HMA.
Our world-class Medicare team partners with clients to meet their needs, address their challenges and improve their bottom line. We provide a variety of services such as:
- Significant support for Medicare Advantage (MA) plans and stakeholders seeking to understand MA policy and operational issues including strategy, market assessment, models of care, evaluation, and audit support.
- Support MA special needs plans (D-SNP, I-SNP, C-SNP, etc.) and programs for dual eligible beneficiaries.
- Medicare regulatory, analytics and thought leadership consulting services for MA plans, providers, suppliers, value-based organizations, associations, and foundations.
- Design, implementation, evaluation and analysis of Medicare value-based payment systems and policy issues.
- Program of All-Inclusive Care for the Elderly (PACE) strategy and operations.
- Strategic advice, policy development, and budgetary analysis for clients seeking assistance with Medicare reform efforts.
- Medicare coverage and reimbursement for device, drug and biotechnology manufacturers and other stakeholders in the life sciences community.
- Assistance for clients seeking to commercialize new technologies.
- MA and fee-for-service claims analysis and actuarial services with support from actuaries within HMA plus actuaries from Wakely Consulting Group and Cirdan Health Systems and Consulting.
- Consulting and federal policy analysis, including Congressional Budget Office (CBO) scoring and legislative policy development with our colleagues from Leavitt Partners.
In 2021, HMA acquired The Moran Company (TMC), which provides extensive expertise in the design, implementation, and evaluation of various healthcare payment systems, with a particular focus on the Medicare program. As we approach the 26th anniversary of TMC’s founding and the third anniversary of joining the HMA portfolio, we want to honor the history and contributions of The Moran Company and remember the late Donald Moran who founded TMC in July 1998. He spent almost 50 years in the health policy community, including many years in government service, serving as executive associate director for Budget and Legislation at the U.S. Office of Management and Budget during the Reagan Administration.
Many of our TMC colleagues worked with Moran for more than a decade, benefiting from his mentoring and exhaustive knowledge of the industry. Since joining, TMC consultants have worked closely with our HMA colleagues and the Medicare team in particular.
As of July 1, we are retiring the Moran brand and logo and fully integrating the company into HMA as part of the Medicare team. We may be dropping the Moran brand name, but not the approach and diligence for which TMC is well known. In particular, HMA will continue to use the same methodologies for Congressional Budget Office scores and Medicare data analyses that have characterized Moran’s work for more than 25 years.
View some of our recent work from our combined team:
- Case study: Appropriate payment for transformative therapies to secure patient access to CAR Ts
- Case study: Patient journey analysis for a new oncology drug
- Case study: Helping life science manufacturers navigate Medicare payment systems
- Report: Medicare Physician Fee Schedule Reform
- Report: Analyzing the Expanded Landscape of Value-Based Entities
- Webinar: D-SNP growth and integration – key implications of the 2025 CMS final rule
